Our data show that both antibodies activating the TRPV6 channel, rb79 and rb82, are not 100% effective in the cell death induction of PCa cells, and thus confirm the hypothesis that only cells which are void of TRPV6 expression will survive the treatment. This evidence concerns the gene TRPV6 and posterior cortical atrophy.